Lv11
68 积分 2023-01-26 加入
To platform or not to platform: Strategic considerations for antibody formulation in early clinical development
7小时前
待确认
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
6天前
已完结
Recent progress in ITP treatment
13天前
已完结
LILRB4 as a novel immunotherapeutic target for multiple diseases
3个月前
已完结
Secretogranin 2 binds LILRB4 resulting in immunosuppression
3个月前
已完结
LILRB4 specific overexpression in myeloid cells promotes tumor progression and immunosuppression in mouse models
3个月前
已完结
Design, Synthesis, and in vitro Evaluation of Multivalent Drug Linkers for High‐Drug‐Load Antibody–Drug Conjugates
3个月前
已完结
A Patent Review on FDA‐Approved Antibody‐Drug Conjugates, Their Linkers and Drug Payloads
3个月前
已完结
Linker Design for The Antibody Drug Conjugates: A Comprehensive Review
3个月前
已完结
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
3个月前
已完结
皖公网安备34019202002308
